In addition, using mouse models of AD, increased choline improved many characteristics of the disease, ranging from inflammation to glucose metabolism and the hallmark amyloid and tau pathology (Dave et al., 2023; Judd et al., 2023a; Judd et al., 2023b). This evidence concerns the gene MAPT and Alzheimer disease.